Michael R. Landauer, Ph.D.

Michael R. Landauer, Ph.D. is currently a radiation countermeasures consultant. He was a principal investigator and a project leader during his more than 30 year career at the Armed Forces Radiobiology Research Institute (AFRRI), an Institute under the auspices of the Uniformed Services University of the Health Sciences (USUHS), a United States Department of Defense University and Medical School. He retired in 2015, and continues to maintain a relationship with AFRRI, where he is currently a Scientist Emeritus. He received his B.S from Rutgers University (1968), his Ph.D. from the University of Illinois (1975) and was a postdoctoral fellow at the Medical College of Virginia.  Dr. Landauer has been the recipient of the "USUHS Distinguished Service Award" and the "AFRRI Radiobiology Research Award" for his discovery of genistein as a radiation protectant. This invention was subsequently patented in the United States and internationally.  He has been invited to present his research findings internationally and is the author of more than 100 scientific publications, book chapters, patents, and technical reports as well as numerous research grants.  Dr. Landauer was the 2008 recipient of the “Outstanding Service Award” presented by the Association of Government Toxicologist, where he served as President of the Society from 1997-1998.  He is a member of the Society of Toxicology, American College of Toxicology, Association of Government Toxicologists, and the Radiation Research Society.